plerixafor has been researched along with Liver Dysfunction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blanchard, J; Caldwell, CC; Edwards, MJ; Freeman, CM; Kuethe, JW; Lentsch, AB; Nojima, H; Quillin, RC; Schuster, R; Wilson, GC | 1 |
1 other study(ies) available for plerixafor and Liver Dysfunction
Article | Year |
---|---|
CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
Topics: Adoptive Transfer; Animals; Benzylamines; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Cyclams; Disease Models, Animal; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hepatocytes; Heterocyclic Compounds; Leukocyte Common Antigens; Leukocytes, Mononuclear; Liver; Liver Diseases; Liver Regeneration; Male; Mice, Inbred C57BL; Receptors, CXCR4; Reperfusion Injury; Signal Transduction; Time Factors | 2015 |